These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6208014)

  • 21. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G; Tenenhouse A; Vachon C
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M; Fredholm BB; Lerner UH
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential actions of phosphodiesterase inhibitors on secretin- and vasoactive intestinal peptide-induced increases in chief cell cAMP.
    Raufman JP; Cosowsky L
    Biochim Biophys Acta; 1988 Jul; 970(3):318-23. PubMed ID: 2456788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of thyroid hormone on regulation of lipolysis and adenosine 3',5'-monophosphate metabolism in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1985 Sep; 117(3):947-53. PubMed ID: 2410243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.
    Lehnert S
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):825-33. PubMed ID: 91600
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormonal regulation of adipocyte particulate "low Km" cAMP phosphodiesterase.
    Manganiello VC; Smith CJ; Newman AH; Rice K; Degerman E; Belfrage P
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):497-511. PubMed ID: 2450112
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.
    Fredholm BB; Lindgren E
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):64-71. PubMed ID: 6322517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
    Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1193-8. PubMed ID: 2481031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF; Moore JB
    Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of the new phosphodiesterase inhibitor griseolic acid on insulin release in rat pancreatic islets.
    Hashimoto N; Makino H; Kanatsuka A; Yamazaki M; Yoshida S
    Arzneimittelforschung; 1990 Oct; 40(10):1098-101. PubMed ID: 1705426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U; Ransjö M; Fredholm BB
    Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of phosphodiesterase inhibitors on Sertoli cell refractoriness: reversal of the impaired androgen aromatization.
    Conti M; Monaco L; Geremia R; Stefanini M
    Endocrinology; 1986 Mar; 118(3):901-8. PubMed ID: 2419118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
    Bertram JS; Faletto MB
    Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site of insulin inhibition of cAMP-stimulated glycogenolysis.
    Gabbay RA; Lardy HA
    J Biol Chem; 1984 May; 259(10):6052-5. PubMed ID: 6202683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes.
    Kuppusamy UR; Das NP
    Biochem Pharmacol; 1992 Oct; 44(7):1307-15. PubMed ID: 1384499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes.
    Kather H
    J Clin Invest; 1990 Jan; 85(1):106-14. PubMed ID: 1688563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.